Healthcare Industry News: peripherally inserted central catheter
News Release - January 11, 2016
Teleflex Acquisition of Nostix, LLC Expands Catheter Tip Placement SolutionsAcquisition Compliments Teleflex’s Existing ARROW Vascular Positioning System (VPS) to now include familiar ECG-only technology for the elimination of chest X-ray
Additionally, an alternative system with novel navigation capability is under development
WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical devices for critical care and surgery, has acquired privately held Nostix, LLC, a Boulder, Colorado developer of innovative tip confirmation systems that are used to increase the accuracy of vascular access device placement. Currently, Nostix’s ECG-only system is being marketed in the United States for use in placement of peripherally inserted central catheters (PICC) and is used as an alternative to X-ray confirmation in adult patients.
“Adding the Nostix product line provides our customers with the ability to implement catheter tip placement solutions that meet their specific therapeutic and budget needs,” said Benson Smith, Chairman, President and CEO of Teleflex. “The ECG-only product and the range of navigation technologies that are under development will complement our ARROW VPS G4 system by diversifying and strengthening our PICC tip confirmation and navigation portfolio and enhance our ability to meet customer needs globally. Strategically, the addition of this technology will support Teleflex’s future expansion into tip confirmation for central venous catheters, chronic hemodialysis catheters and ports. We also gain access to an innovative product development pipeline, which includes integrated ultrasound capabilities that will extend our ability to offer differentiated catheter tip positioning solutions well into the future.”
The financial terms of the transaction were not disclosed.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit www.teleflex.com.
Teleflex is the home of ARROW®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch® and Weck® – trusted brands united by a common sense of purpose.
About Nostix, LLC
Nostix, LLC is a privately held medical technology company that develops and commercializes differentiated PICC tip placement confirmation and navigation products. It was founded in 2001 and is headquartered in Boulder, Colorado.
JMP Securities LLC served as exclusive financial advisor to Nostix in the transaction.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, ARROW, Deknatel, Hudson RCI, LMA, Pilling, Rüsch and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.